Loading...
AdaptHealth Corp.
AHCO•NASDAQ
Healthcare
Medical - Devices
$9.44
$0.22(2.39%)
AdaptHealth Corp. (AHCO) Financial Performance & Income Statement Overview
Review AdaptHealth Corp.’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revenue Growth
1.90%
↑ 1.90%
Operating Income Growth
144.07%
↑ 144.07%
Net Income Growth
113.32%
↑ 113.32%
Operating Cash Flow Growth
12.73%
↑ 12.73%
Operating Margin
7.97%
↑ 7.97%
Gross Margin
15.61%
↑ 15.61%
Net Profit Margin
2.80%
↑ 2.80%
ROE
5.56%
↑ 5.56%
ROIC
6.29%
↑ 6.29%
AdaptHealth Corp. (AHCO) Income Statement & Financial Overview
Review AdaptHealth Corp.'s (AHCO) income statement with detailed quarterly and annual figures.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | $856.64M | $805.86M | $805.98M | $792.50M |
| Cost of Revenue | $543.35M | $681.87M | $690.37M | $687.06M |
| Gross Profit | $313.30M | $123.99M | $115.61M | $105.44M |
| Gross Profit Ratio | $0.37 | $0.15 | $0.14 | $0.13 |
| R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
| SG&A Expenses | $225.61M | $49.24M | $57.01M | $48.38M |
| Operating Expenses | $833.28M | $49.24M | $57.01M | $48.38M |
| Total Costs & Expenses | $758.98M | $742.37M | $747.38M | $735.44M |
| Interest Income | $0.00 | $0.00 | $0.00 | $0.00 |
| Interest Expense | $29.73M | $31.43M | $33.04M | $32.47M |
| Depreciation & Amortization | $11.02M | $90.76M | $100.74M | $105.86M |
| EBITDA | $110.32M | $154.22M | $161.56M | $144.23M |
| EBITDA Ratio | $0.13 | $0.19 | $0.20 | $0.18 |
| Operating Income | $97.67M | $63.49M | $58.59M | $57.06M |
| Operating Income Ratio | $0.11 | $0.08 | $0.07 | $0.07 |
| Other Income/Expenses (Net) | -$26.96M | -$31.46M | -$24.27M | -$45.03M |
| Income Before Tax | $70.71M | $32.03M | $27.78M | $5.50M |
| Income Before Tax Ratio | $0.08 | $0.04 | $0.03 | $0.007 |
| Income Tax Expense | $19.31M | $8.07M | $7.25M | $6.61M |
| Net Income | $50.26M | $22.86M | $19.43M | -$2.13M |
| Net Income Ratio | $0.06 | $0.03 | $0.02 | -$0.003 |
| EPS | $0.41 | $0.16 | $0.13 | -$0.02 |
| Diluted EPS | $0.40 | $0.15 | $0.13 | -$0.02 |
| Weighted Avg Shares Outstanding | $134.57M | $134.30M | $133.22M | $132.91M |
| Weighted Avg Shares Outstanding (Diluted) | $136.53M | $136.53M | $136.03M | $132.91M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan